BlackRock Institutional Trust’s Plus Therapeutics PSTV Stock Holding History

BlackRock Institutional Trust’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$383K	Hold	1	–	–	﹤0.01%	3501
2016 Q3	$514K	Hold	1	–	–	﹤0.01%	3478
2016 Q2	$533K	Hold	1	–	–	﹤0.01%	3478
2016 Q1	$810K	Hold	1	–	–	﹤0.01%	3340
2015 Q4	$703K	Hold	1	–	–	﹤0.01%	3416
2015 Q3	$1.29M	Hold	1	–	–	﹤0.01%	3255
2015 Q2	$1.53M	Hold	1	–	–	﹤0.01%	3220
2015 Q1	$4.14M	Hold	1	–	–	﹤0.01%	2818
2014 Q4	$1.45M	Hold	1	–	–	﹤0.01%	3246
2014 Q3	$1.89M	Hold	1	–	–	﹤0.01%	3101
2014 Q2	$5.97M	Hold	1	–	–	﹤0.01%	2702
2014 Q1	$6.57M	Hold	1	–	–	﹤0.01%	2667
2013 Q4	$5.82M	Hold	1	–	–	﹤0.01%	2711
2013 Q3	$5.09M	Hold	1	–	–	﹤0.01%	2725
2013 Q2	$5.16M	Buy	+1	New	+$7M	﹤0.01%	2682

Other funds holding PSTV

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Institutional Trust's PSTV Position: Q4 2016 in Review

BlackRock Institutional Trust held its Plus Therapeutics (PSTV) position steady in Q4 2016 at 1 share worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #3501.

BlackRock Institutional Trust first reported a position in PSTV in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.57M in Q1 2014. 4 funds tracked by Wall St. Rank hold PSTV as of Q4 2016.

BlackRock Institutional Trust held 1 share of Plus Therapeutics worth $383K as of Q4 2016.
BlackRock Institutional Trust left its Plus Therapeutics share count unchanged in Q4 2016.
Plus Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3501 holding.
BlackRock Institutional Trust first reported a position in Plus Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Plus Therapeutics position peaked at $6.57M in Q1 2014.
4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.